Health Tech

The Future of Genome Sequencing | Veritas Chief Marketing & Design Officer Rodrigo Martinez

By JESSICA DAMASSA, WTF HEALTH

DNA testing companies like 23andMe have opened the genome market in the last decade, with adoption skyrocketing on both consumer and clinical sides. Now the trend is pushing even further, from genotyping technology to whole genome sequencing and the health implications are massive. While genotyping looks at less than half of 1% of your genome, whole genome sequencing looks at over 99% of your genome. That’s about 6.4 billion letters of DNA! With elite awards from MIT, Fast Company, and more, Veritas Genetics is not only designing great, user-friendly experiences for people to engage with their personal genome information, but taking it a step further by providing actionable insights that actually result in a healthier life.

Filmed at the JP Morgan Healthcare Conference in San Francisco, CA, January 2019.

Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew Holt.

Get a glimpse of the future of healthcare by meeting the people who are going to change it. Find more WTF Health interviews here or check out www.wtf.health